IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease
Authors:
Open Access
- 27 October 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 23 (11) , 679-691
Abstract
Lung disease due to Mycobacterium avium complex (MAC) organisms is increasing. A greater understanding of the host immune response to MAC organisms will provide a foundation to develop novel therapies for these recalcitrant infections. IL-32 is a newly described pro-inflammatory cytokine that enhances host immunity against various microbial pathogens. Cytokines that induce IL-32 such as interferon-gamma, IL-18, IL-12 and tumor necrosis factor-alpha are of considerable importance to mycobacterial immunity. We performed immunohistochemistry and morphometric analysis to quantify IL-32 expression in the lungs of 11 patients with MAC lung disease and 10 controls with normal lung tissues. After normalizing for basement membrane length, there was a profound increase in IL-32 expression in the airway epithelial cells of the MAC-infected lungs compared with controls. Following normalization for alveolar surface area, there was a trend toward increased IL-32 expression in type II alveolar cells and alveolar macrophages in the lungs of MAC patients. Human airway epithelial cells (BEAS-2B) infected with M. avium produced IL-32 by a nuclear factor-kappa B-dependent mechanism. In both BEAS-2B cells and human monocyte-derived macrophages, exogenous IL-32γ significantly reduced the growth of intracellular M. avium. This finding was corroborated by an increase in the number of intracellular M. avium recovered from THP-1 monocytes silenced for endogenous IL-32 expression. The anti-mycobacterial effect of IL-32 may be due, in part, to increased apoptosis of infected cells. These findings indicate that IL-32 facilitates host defense against MAC organisms but may also contribute to the airway inflammation associated with MAC pulmonary disease.Keywords
This publication has 71 references indexed in Scilit:
- IL-17 and Th17 cells in tuberculosisCytokine & Growth Factor Reviews, 2010
- Paradoxical effects of constitutive human IL-32γ in transgenic mice during experimental colitisProceedings of the National Academy of Sciences, 2010
- A role for IL‐18 in protective immunity against Mycobacterium tuberculosisEuropean Journal of Immunology, 2010
- A proinflammatory cytokine interleukin‐32β promotes the production of an anti‐inflammatory cytokine interleukin‐10Immunology, 2009
- Identification of the most active interleukin‐32 isoformImmunology, 2009
- IL-23 and IL-17 in tuberculosisCytokine, 2008
- Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunityCurrent Opinion in Immunology, 2007
- Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003Thorax, 2007
- Epithelial overexpression of interleukin-32α in inflammatory bowel diseaseClinical and Experimental Immunology, 2007
- IL-32, a novel cytokine with a possible role in diseaseAnnals of the Rheumatic Diseases, 2006